{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:14:36Z","timestamp":1792512876880,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4363-y","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T16:03:10Z","timestamp":1565798590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections"],"prefix":"10.1186","volume":"19","author":[{"given":"Thomas P.","family":"Lodise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Gidaya","family":"Bonine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatao Michael","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Folse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"key":"4363_CR1","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available at: \n                    http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf\n                    \n                  . Accessed 8 Aug 2019."},{"key":"4363_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318\u201327.","journal-title":"Lancet Infect Dis"},{"key":"4363_CR3","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1128\/AAC.00338-07","volume":"51","author":"TP Lodise Jr","year":"2007","unstructured":"Lodise TP Jr, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, Lomaestro B, McGregor JC. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007;51:3510\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"4363_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2125.2005.02443.x","volume":"60","author":"MC Sturkenboom","year":"2005","unstructured":"Sturkenboom MC, Goettsch WG, Picelli G, in\u2019t veld B, Yin DD, de Jong RB, Go PM, Herings RM. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol. 2005;60:438\u201343.","journal-title":"Br J Clin Pharmacol"},{"key":"4363_CR5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1080\/00365540701449377","volume":"39","author":"JM Tellado","year":"2007","unstructured":"Tellado JM, Sen SS, Caloto MT, Kumar RN, Nocea G. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain. Scand J Infect Dis. 2007;39:947\u201355.","journal-title":"Scand J Infect Dis"},{"key":"4363_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12879-015-1123-5","volume":"15","author":"G Raman","year":"2015","unstructured":"Raman G, Avendano E, Berger S, Menon V. Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis. BMC Infect Dis. 2015;15:395.","journal-title":"BMC Infect Dis"},{"key":"4363_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1378\/chest.122.1.262","volume":"122","author":"M Iregui","year":"2002","unstructured":"Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002;122:262\u20138.","journal-title":"Chest."},{"key":"4363_CR8","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1093\/ofid\/ofx163.637","volume":"4","author":"NG Bonine","year":"2017","unstructured":"Bonine NG, Berger A, Altincatal A, Wang R, Bhagnani T, Gillard P, Lodise T. Associations between timeliness of therapy and clinical and economic outcomes among patients with serious infections due to gram-negative bacteria (GNB): how much does delayed appropriate therapy (DAT) matter? Open Forum Infect Dis. 2017;4:S283\u20134.","journal-title":"Open Forum Infect Dis"},{"key":"4363_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12879-017-2383-z","volume":"17","author":"MD Zilberberg","year":"2017","unstructured":"Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC Infect Dis. 2017;17:279.","journal-title":"BMC Infect Dis"},{"key":"4363_CR10","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1086\/375057","volume":"36","author":"TP Lodise","year":"2003","unstructured":"Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003;36:1418\u201323.","journal-title":"Clin Infect Dis"},{"key":"4363_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cmi.2015.12.002","volume":"22","author":"ND Friedman","year":"2016","unstructured":"Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22:416\u201322.","journal-title":"Clin Microbiol Infect"},{"key":"4363_CR12","doi-asserted-by":"publisher","first-page":"S397","DOI":"10.1093\/cid\/cir153","volume":"52","author":"B Spellberg","year":"2011","unstructured":"Infectious Diseases Society of America, Spellberg B, Blaser M, Guidos RJ, Boucher HW, Bradley JS, Eisenstein BI, Gerding D, Lynfield R, Reller LB, et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis. 2011;52:S397\u2013428.","journal-title":"Clin Infect Dis"},{"key":"4363_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159\u201377.","journal-title":"Clin Infect Dis"},{"key":"4363_CR14","unstructured":"World Health Organization. Global Action Plan on Antimicrobial Resistance. Available at: \n                    http:\/\/www.who.int\/antimicrobial-resistance\/global-action-plan\/en\/\n                    \n                  . Accessed 8 Aug 2019."},{"key":"4363_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1378\/chest.115.2.462","volume":"115","author":"MH Kollef","year":"1999","unstructured":"Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462\u201374.","journal-title":"Chest."},{"key":"4363_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1365-2796.1998.00379.x","volume":"244","author":"L Leibovici","year":"1998","unstructured":"Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998;244:379\u201386.","journal-title":"J Intern Med"},{"key":"4363_CR17","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1128\/AAC.00338-07","volume":"51","author":"TPJ Lodise","year":"2007","unstructured":"Lodise TPJ, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, Lomaestro B, McGregor JC. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007;51:3510\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"4363_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s12879-018-3524-8","volume":"18","author":"TP Lodise","year":"2018","unstructured":"Lodise TP, Zhao Q, Fahrbach K, Gillard PJ, Martin A. A systematic review of the association between delayed appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia coli: how long is too long? BMC Infect Dis. 2018;18:625.","journal-title":"BMC Infect Dis"},{"key":"4363_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.amjms.2018.11.009","volume":"357","author":"NG Bonine","year":"2019","unstructured":"Bonine NG, Berger A, Altincatal A, Wang R, Bhagnani T, Gillard P, Lodise T. Impact of delayed appropriate antibiotic therapy on patient outcomes by antibiotic resistance status from serious gram-negative bacterial infections. Am J Med Sci. 2019;357:103\u201310.","journal-title":"Am J Med Sci"},{"key":"4363_CR20","unstructured":"Premier Life Sciences. Premier Healthcare Database: Data that Informs and Performs. Premier Inc. Available at: \n                    https:\/\/www.premierinc.com\/downloads\/PremierHealthcareDatabaseWhitepaper.pdf\n                    \n                  . Accessed 8 Aug 2019."},{"key":"4363_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"4363_CR22","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.ajic.2018.02.022","volume":"46","author":"CE Edmiston","year":"2018","unstructured":"Edmiston CE, Garcia R, Barnden M, DeBaun B, Johnson HB. Rapid diagnostics for bloodstream infections: a primer for infection preventionists. Am J Infect Control. 2018;46:1060\u20138.","journal-title":"Am J Infect Control"},{"key":"4363_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ajic.2015.09.006","volume":"44","author":"BM Miller","year":"2016","unstructured":"Miller BM, Johnson SW. Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: development of a bedside clinical score for risk assessment. Am J Infect Control. 2016;44:134\u20137.","journal-title":"Am J Infect Control"},{"key":"4363_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1086\/380967","volume":"38","author":"F Jaimes","year":"2004","unstructured":"Jaimes F, Arango C, Ruiz G, Cuervo J, Botero J, Velez G, Upegui N, Machado F. Predicting bacteremia at the bedside. Clin Infect Dis. 2004;38:357\u201362.","journal-title":"Clin Infect Dis"},{"key":"4363_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000752","volume":"3","author":"G Mariscalco","year":"2014","unstructured":"Mariscalco G, Biancari F, Zanobini M, Cottini M, Piffaretti G, Saccocci M, Banach M, Beghi C, Angelini GD. Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score. J Am Heart Assoc. 2014;3:e000752.","journal-title":"J Am Heart Assoc"},{"key":"4363_CR26","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1161\/CIRCULATIONAHA.106.635573","volume":"114","author":"RH Mehta","year":"2006","unstructured":"Mehta RH, Grab JD, O'Brien SM, Bridges CR, Gammie JS, Haan CK, Ferguson TB, Peterson ED. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation. 2006;114:2208\u201316 quiz.","journal-title":"Circulation"},{"key":"4363_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12879-014-0615-z","volume":"14","author":"A Vasudevan","year":"2014","unstructured":"Vasudevan A, Mukhopadhyay A, Li J, Yuen EG, Tambyah PA. A prediction tool for nosocomial multi-drug resistant gram-negative bacilli infections in critically ill patients - prospective observational study. BMC Infect Dis. 2014;14:615.","journal-title":"BMC Infect Dis"},{"key":"4363_CR28","doi-asserted-by":"publisher","first-page":"O804","DOI":"10.1111\/1469-0691.12633","volume":"20","author":"E Bilavsky","year":"2014","unstructured":"Bilavsky E, Temkin E, Lerman Y, Rabinovich A, Salomon J, Lawrence C, Rossini A, Salvia A, Samso JV, Fierro J, et al. Risk factors for colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae on admission to rehabilitation centres. Clin Microbiol Infect. 2014;20:O804\u201310.","journal-title":"Clin Microbiol Infect"},{"key":"4363_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2015.07.010","volume":"39","author":"B Denis","year":"2015","unstructured":"Denis B, Lafaurie M, Donay JL, Fontaine JP, Oksenhendler E, Raffoux E, Hennequin C, Allez M, Socie G, Maziers N, et al. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study. Int J Infect Dis. 2015;39:1\u20136.","journal-title":"Int J Infect Dis"},{"key":"4363_CR30","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1086\/648451","volume":"30","author":"LB Gasink","year":"2009","unstructured":"Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009;30:1180\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4363_CR31","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3201\/eid1308.070071","volume":"13","author":"AD Harris","year":"2007","unstructured":"Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, Hebden JN, Morris JG Jr. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis. 2007;13:1144\u20139.","journal-title":"Emerg Infect Dis"},{"key":"4363_CR32","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","volume":"17","author":"O Zarkotou","year":"2011","unstructured":"Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, Prekates A, Themeli-Digalaki K, Tsakris A. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17:1798\u2013803.","journal-title":"Clin Microbiol Infect"},{"key":"4363_CR33","doi-asserted-by":"publisher","first-page":"ofy091","DOI":"10.1093\/ofid\/ofy091","volume":"5","author":"T Sullivan","year":"2018","unstructured":"Sullivan T, Ichikawa O, Dudley J, Li L, Aberg J. The rapid prediction of carbapenem resistance in patients with Klebsiella pneumoniae bacteremia using electronic medical record data. Open Forum Infect Dis. 2018;5:ofy091.","journal-title":"Open Forum Infect Dis"},{"key":"4363_CR34","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/cid\/ciw425","volume":"63","author":"KE Goodman","year":"2016","unstructured":"Goodman KE, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Massey CJ, Tamma PD. A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum beta-lactamase-producing organism. Clin Infect Dis. 2016;63:896\u2013903.","journal-title":"Clin Infect Dis"},{"key":"4363_CR35","first-page":"8296720","volume":"2018","author":"Y Yu","year":"2018","unstructured":"Yu Y, Shen H, Zhu C, Guo R, Gao Y, Lu L. Infections caused by extended-spectrum beta-lactamase producing Escherichia coli in systemic lupus erythematosus patients: prevalence, risk factors, and predictive model. Biomed Res Int. 2018;2018:8296720.","journal-title":"Biomed Res Int"},{"key":"4363_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/AAC.00851-06","volume":"51","author":"TP Lodise","year":"2007","unstructured":"Lodise TP, Miller CD, Graves J, Furuno JP, McGregor JC, Lomaestro B, Graffunder E, McNutt LA. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob Agents Chemother. 2007;51:417\u201322.","journal-title":"Antimicrob Agents Chemother"},{"key":"4363_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/aje\/kws241","volume":"177","author":"S Rose","year":"2013","unstructured":"Rose S. Mortality risk score prediction in an elderly population using machine learning. Am J Epidemiol. 2013;177:443\u201352.","journal-title":"Am J Epidemiol"},{"key":"4363_CR38","first-page":"325","volume":"19","author":"Y Li","year":"2018","unstructured":"Li Y, Wu FX, Ngom A. A review on machine learning principles for multi-view biological data integration. Brief Bioinform. 2018;19:325\u201340.","journal-title":"Brief Bioinform"},{"key":"4363_CR39","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/bib\/bbx124","volume":"20","author":"F Degenhardt","year":"2019","unstructured":"Degenhardt F, Seifert S, Szymczak S. Evaluation of variable selection methods for random forests and omics data sets. Brief Bioinform. 2019;20:492\u2013503.","journal-title":"Brief Bioinform."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4363-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4363-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4363-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T23:12:23Z","timestamp":1597273943000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4363-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4363"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4363-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,14]]},"assertion":[{"value":"19 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable; the database is fully de-identified and compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Given the de-identified and retrospective nature of the data and the noninterventional study design, written patient consent was neither required nor sought. Administrative permissions were not required to access the raw data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; individual patient data are not presented.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors met the International Committee of Medical Journal Editors (ICMJE) authorship criteria. Neither honoraria nor payments were made for authorship. TL has received consulting fees or honoraria from Allergan plc. He has also been a consultant for Merck and The Medicines Company and has received payment for lectures, including service on speaker bureaus for Allergan for work not associated with the current study. NGB, JMY, and PG are employees of Allergan. HJF is an employee of Evidera, a healthcare consulting and contract research firm. In his salaried positions, he is precluded from receiving payment or honoraria directly from organizations for services rendered. Evidera has received funding for the study from Allergan and has received funding from many other biomedical companies in support of various research studies and projects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"718"}}